NYSEAMERICAN:MYO Myomo (MYO) Stock Price, News & Analysis $0.88 -0.04 (-4.23%) Closing price 04:10 PM EasternExtended Trading$0.91 +0.03 (+3.52%) As of 05:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartEarningsInsider TradesNews and TrendsOwnershipSEC Filings About Myomo Stock (NYSEAMERICAN:MYO) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Myomo alerts:Sign Up Key Stats Today's Range$0.87▼$0.9450-Day Range$0.92▼$1.6752-Week Range$0.61▼$1.89Volume295,726 shsAverage Volume531,497 shsMarket Capitalization$35.29 millionP/E RatioN/ADividend YieldN/APrice Target$10.00Consensus RatingBuy Company Overview Myomo, Inc. is a medical robotics company that develops wearable devices to help people with upper-limb weakness or paralysis regain arm and hand movement. Its products are designed for people with conditions such as stroke, spinal cord injury, brachial plexus injury and other neuromuscular disorders. The company’s principal product, the MyoPro, is a powered upper-limb orthosis. Sensors detect electrical signals from a user’s muscles, and the device provides assistance to support movements such as bending the elbow and opening or closing the hand. Myomo provides device fitting, training and support, working with patients and healthcare professionals to assess needs and coordinate access to its products. The company is headquartered in the Boston area and serves patients in the United States and select international markets.AI Generated. May Contain Errors. Read More Myomo Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks61st Percentile Overall ScoreMYO MarketRank™: 3.054226475275 of 5 starsMyomo scored higher than 61% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingMyomo has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 2 buy ratings, no hold ratings, and no sell ratings.Upside PotentialMyomo has a consensus price target of $10.00, representing about 1,005.0% upside from its current price of $0.91.Amount of Analyst CoverageMyomo has received no research coverage in the past 90 days.Read more about Myomo's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Myomo are expected to grow in the coming year, from ($0.31) to ($0.17) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Myomo is -2.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Myomo is -2.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMyomo has a P/B Ratio of 12.93. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted3.32% of the float of Myomo has been sold short.Short Interest Ratio / Days to CoverMyomo has a short interest ratio ("days to cover") of 5.75.Change versus previous monthShort interest in Myomo has recently increased by 8.65%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldMyomo does not currently pay a dividend.Dividend GrowthMyomo does not have a long track record of dividend growth. News and Social Media4.3 / 5News Sentiment0.91 News SentimentMyomo has a news sentiment score of 0.91. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.52 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 12 news articles for Myomo this week, compared to 2 articles on an average week.Search Interest3 people have searched for MYO on MarketBeat in the last 30 days. MarketBeat Follows1 people have added Myomo to their MarketBeat watchlist in the last 30 days. Company Ownership1.7 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Myomo insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $70,662.00 in company stock.Percentage Held by Insiders12.14% of the stock of Myomo is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions44.99% of the stock of Myomo is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Myomo's insider trading history. Receive MYO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Myomo and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MYO Stock News HeadlinesWhat is HC Wainwright's Forecast for Myomo FY2026 Earnings?November 14, 2026 | americanbankingnews.comMyomo, Inc. Q3 2026 Earnings Call SummaryNovember 10, 2026 | finance.yahoo.comYou missed yesterday's deadline…In June 2025, a drilling crew near the Grand Canyon uncovered an energy source producing nearly eight times the output of Saudi Arabia's largest oil well, enough potential energy to power civilization for two million years. While the One Big Beautiful Bill Act stripped tax credits from solar, wind, and EVs on July 4th, this discovery was reclassified alongside oil and nuclear and secured eight years of credits. Google signed a 15-year contract, and Bill Gates committed 100 million dollars.November 18 at 1:00 AM | Behind the Markets (Ad)Myomo, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026November 10, 2026 | marketscreener.comMTranscript : Myomo, Inc., Q3 2026 Earnings Call, Nov 09, 2026November 9, 2026 | marketscreener.comMMyomo narrows 2026 revenue guidance to $46M-$47M as it expects modest sequential gross margin improvement in Q4November 9, 2026 | seekingalpha.comMyomo (MYO) Q3 2026 Earnings Call TranscriptNovember 9, 2026 | finance.yahoo.comMyomo, Inc. (MYO) Q3 2026 Earnings Call TranscriptNovember 9, 2026 | seekingalpha.comSee More Headlines MYO Stock Analysis - Frequently Asked Questions How have MYO shares performed this year? Myomo's stock was trading at $0.91 at the beginning of 2026. Since then, MYO shares have decreased by 0.5% and is now trading at $0.9050. How were Myomo's earnings last quarter? Myomo, Inc. (NYSEAMERICAN:MYO) issued its quarterly earnings data on Monday, November, 9th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.08) by $0.01. The business earned $12.33 million during the quarter, compared to analysts' expectations of $11.51 million. Myomo had a negative trailing twelve-month return on equity of 183.47% and a negative net margin of 33.14%. Read the conference call transcript. Who are Myomo's major shareholders? Myomo's top institutional investors include Palumbo Wealth Management LLC (0.69%), Marshall Wace LLP (0.56%), State Street Corp (0.26%) and Goldman Sachs Group Inc. (0.14%). Insiders that own company stock include Paul R Gudonis, Thomas F Kirk, Milton Mayo Morris, Micah Mitchell, Harry Kovelman and Thomas Aloysius Jr Crowley. View institutional ownership trends. How do I buy shares of Myomo? Shares of MYO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Myomo own? Based on aggregate information from My MarketBeat watchlists, some other companies that Myomo investors own include Advanced Micro Devices (AMD), Plug Power (PLUG), Remark (MARK), NIO (NIO), Block (XYZ), Micron Technology (MU) and SoundHound AI (SOUN). Company Calendar Last Earnings11/09/2026Today11/18/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (2d) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 As of 2 days ago, MYO's financial health entered the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNYSEAMERICAN:MYO CIK1369290 Webmyomo.com Phone(617) 996-9058FaxN/AEmployees195Year FoundedN/APrice Target and Rating Average Price Target for Myomo$10.00 High Price Target$10.00 Low Price Target$10.00 Potential Upside/Downside+1,036.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)($0.23) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$15.57 million Net Margins-33.14% Pretax Margin-32.24% Return on Equity-183.47% Return on Assets-36.79% Debt Debt-to-Equity Ratio4.24 Current Ratio1.92 Quick Ratio1.66 Sales & Book Value Annual Sales$40.93 million Price / Sales0.86 Cash FlowN/A Price / Cash FlowN/A Book Value$0.07 per share Price / Book12.57Miscellaneous Outstanding Shares40,100,000Free Float35,231,000Market Cap$35.29 million OptionableNot Optionable Beta1.74 The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NYSEAMERICAN:MYO) was last updated on 11/18/2026 by MarketBeat.com Staff. From Our PartnersPentagon magnet restrictions take effect January 1, 2027A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It...OilPrice | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredBeyond NVDA: The World’s Next #1 Company?This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvi...Banyan Hill Publishing | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Myomo, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Myomo With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.